Abstract:Major depression is a common and severe psychiatric disorder with a highly polygenic genetic architecture. Genome-wide association studies have successfully identified multiple independent genetic loci that harbour variants associated with major depression, but the exact causal genes and biological mechanisms are largely unknown. Tissue-specific network approaches may identify molecular mechanisms underlying major depression and provide a biological substrate for integrative analyses. We provide a framework for the identification of individual risk genes and gene co-expression networks using genome-wide association summary statistics and gene expression information across multiple human brain tissues and whole blood. We developed a novel gene-based method called eMAGMA that leverages tissue-specific eQTL information to identify 99 biologically plausible risk genes associated with major depression, of which 58 are novel. Among these novel associations is Complement Factor 4A (C4A), recently implicated in schizophrenia through its role in synaptic pruning during postnatal development. Major depression risk genes were enriched in gene co-expression modules in multiple brain tissues and the implicated gene modules contained genes involved in synaptic signalling, neuronal development, and cell transport pathways. Modules enriched with major depression signals were strongly preserved across brain tissues, but were weakly preserved in whole blood, highlighting the importance of using disease-relevant tissues in genetic studies of psychiatric traits. We identified tissue-specific genes and gene co-expression networks associated with major depression. Our novel analytical framework can be used to gain fundamental insights into the functioning of the nervous system in major depression and other brain-related traits.Although genome-wide association studies have identified genetic risk variants associated with major depression, our understanding of the mechanisms through which they influence disease susceptibility remains largely unknown. Genetic risk variants are highly enriched in non-coding regions of the genome and affect gene expression. Genes are co-expressed and regulate the activity of one another to form highly organized networks. In this study, we generate tissue-specific gene co-expression networks, each containing groups of functionally related genes or "modules", to delineate gene co-expression and thereby facilitate the identification of gene processes in major depression. We developed and applied a novel research methodology (called "eMAGMA") which integrates genetic and transcriptomic information in a tissue-specific analysis to identify risk genes and test for their enrichment in gene co-expression modules. Using this novel approach, we identified gene modules in multiple tissues that are both enriched with major depression genetic association signals and biologically meaningful pathways. We also show the disease implicated gene modules are strongly preserved across brain regions, but not in whole blood, suggesting unique patterns of gene co-expression within the two tissue types. Our novel analytical framework provides important insights into the functional genetics major depression and can be applied to other neuropsychiatric disorders.

Gray matter volumetric correlates of the polygenic risk of depression: A study of the Human Connectome Project data

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

Genome-Wide Association Analysis With Gray Matter Volume As A Quantitative Phenotype In First-Episode Treatment-Naive Patients With Schizophrenia

Genetic Evidence Suggests a Genetic Association Between Major Depressive Disorder and Reduced Cortical Gray Matter Volume: A Mendelian Randomization Study and Mediation Analysis.

Investigating the shared genetic architecture between depression and subcortical volumes

Polygenic risk for depression and resting state functional connectivity of subgenual anterior cingulate cortex in young adults

Gray Matter Volume Abnormalities in Individuals with Cognitive Vulnerability to Depression: a Voxel-Based Morphometry Study.

Polygenic Risk Score for Five Major Psychiatric Disorders Associated with Volume of Distinct Brain Regions in the General Population

Gray matter volume abnormalities were associated with sustained attention in unmedicated major depression.

Gray Matter Volume Abnormalities in Depressive Patients with and Without Anxiety Disorders.

The Depression GWAS Risk Allele Predicts Smaller Cerebellar Gray Matter Volume and Reduced SIRT1 Mrna Expression in Chinese Population

162. Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6P22.1

Gray Matter Volume Abnormalities in Vascular Cognitive Impairment and Their Association with Gene Expression Profiles

A gene co-expression network-based analysis of multiple brain tissues reveals novel genes and molecular pathways underlying major depression

Gray matter atrophy is constrained by normal structural brain network architecture in depression

Gray matter volume correlates of Comorbid Depression in Autism Spectrum Disorder

Relationship Between Personality and Gray Matter Volume in Healthy Young Adults: A Voxel-Based Morphometric Study

Convergent molecular and structural neuroimaging signatures of first-episode depression

Gray matter structures associated with neuroticism: A meta‐analysis of whole‐brain voxel‐based morphometry studies

Voxelwise Meta-Analysis of Gray Matter Reduction in Major Depressive Disorder

Gray matter volume reduction in orbitofrontal cortex correlated with plasma glial cell line-derived neurotrophic factor (GDNF) levels within major depressive disorder